“ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME”. CAHIERS MAGELLANES-NS, vol. 6, no. 2, Sept. 2024, pp. 4972-83, http://cahiersmagellanes.com/index.php/CMN/article/view/782.